THE VALUED VOICE

Thursday, January 27, 2022

   

Dr. Scott Gottlieb to Keynote WHA’s Advocacy Day

Speaker sponsored by Quarles & Brady
The opening keynote at WHA’s annual Advocacy Day event will be delivered by Scott Gottlieb, MD. Quarles & Brady is sponsoring Dr. Gottlieb’s appearance. 

Gottlieb is a physician and former Commissioner of the U.S. Food and Drug Administration. His work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping health care delivery and expanding consumer choice and safety. Gottlieb serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
 

Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and is a regular contributor to CNBC. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. In 2018, 2019 and then again in 2020, Modern Healthcare named Dr. Gottlieb the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb is also the author of New York Times Bestseller Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.

Read Dr. Gottlieb's full biography here.

"Quarles & Brady is always pleased to support WHA's Advocacy Day event, and this year we are thrilled to sponsor this very exciting keynote," said Quarles and Brady Partner Sarah Coyne. "Dr. Scott Gottlieb is a nationally respected leader in public health and health care policy, and his remarks are sure to be extremely relevant and timely," Coyne continued.

Advocacy Day 2022 will take place Wednesday, March 23, 2022, from 8:30 to 11:45 a.m. WHA will again deliver this event to advocates across the state virtually via the professional events platform LeaderPass. The keynote portion of the program, featuring Dr. Gottlieb, will be presented in a moderated discussion format with WHA President and CEO Eric Borgerding. Other elements of the program include the bipartisan legislative panel (to be announced soon), legislative issues briefing and grassroots legislative visits. 

WHA encourages and invites hospital CEOs, CFOs, managers, nurse executives, quality managers, hospital volunteers, hospital trustees, WHA Hospitals Education & Advocacy Team (HEAT)  grassroots members, Partners of WHA members, WHA corporate members and any other hospital staff interested in helping to shape the future of health care in Wisconsin communities to attend.

There is no cost to attend Advocacy Day, but registration is required. Register here.

 

This story originally appeared in the January 27, 2022 edition of WHA Newsletter

WHA Logo
Thursday, January 27, 2022

Dr. Scott Gottlieb to Keynote WHA’s Advocacy Day

Speaker sponsored by Quarles & Brady
The opening keynote at WHA’s annual Advocacy Day event will be delivered by Scott Gottlieb, MD. Quarles & Brady is sponsoring Dr. Gottlieb’s appearance. 

Gottlieb is a physician and former Commissioner of the U.S. Food and Drug Administration. His work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping health care delivery and expanding consumer choice and safety. Gottlieb serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
 

Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and is a regular contributor to CNBC. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. In 2018, 2019 and then again in 2020, Modern Healthcare named Dr. Gottlieb the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb is also the author of New York Times Bestseller Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.

Read Dr. Gottlieb's full biography here.

"Quarles & Brady is always pleased to support WHA's Advocacy Day event, and this year we are thrilled to sponsor this very exciting keynote," said Quarles and Brady Partner Sarah Coyne. "Dr. Scott Gottlieb is a nationally respected leader in public health and health care policy, and his remarks are sure to be extremely relevant and timely," Coyne continued.

Advocacy Day 2022 will take place Wednesday, March 23, 2022, from 8:30 to 11:45 a.m. WHA will again deliver this event to advocates across the state virtually via the professional events platform LeaderPass. The keynote portion of the program, featuring Dr. Gottlieb, will be presented in a moderated discussion format with WHA President and CEO Eric Borgerding. Other elements of the program include the bipartisan legislative panel (to be announced soon), legislative issues briefing and grassroots legislative visits. 

WHA encourages and invites hospital CEOs, CFOs, managers, nurse executives, quality managers, hospital volunteers, hospital trustees, WHA Hospitals Education & Advocacy Team (HEAT)  grassroots members, Partners of WHA members, WHA corporate members and any other hospital staff interested in helping to shape the future of health care in Wisconsin communities to attend.

There is no cost to attend Advocacy Day, but registration is required. Register here.

 

This story originally appeared in the January 27, 2022 edition of WHA Newsletter

Other Articles in this Issue